Tacrolimus nephrotoxicity: beware of the association of diarrhea, drug interaction and pharmacogenetics
- 21 January 2010
- journal article
- case report
- Published by Springer Nature in Pediatric Nephrology
- Vol. 25 (5) , 965-969
Abstract
Tacrolimus is known to potentially lead to adverse events in recipients with diarrhoea and/or calcium channel blocker (CCB) co-administration. We report a renal transplant recipient who suffered from severe nephrotoxicity related to a toxic tacrolimus trough concentration in both conditions, diarrhoea and CCB co-administration, and with genotyped CYP3A system and P-glycoprotein (P-gp) polymorphisms. To our knowledge, this is the first case to be investigated for such polymorphisms. Clinicians should be reminded of the possibility of highly increased levels of tacrolimus in situations of diarrhoea and/or co-administration of CCBs. It also highlights the key role in tacrolimus pharmacokinetics of the CYP3A system and P-gp polymorphisms, and their influence in high-risk situations when enzyme activity is already affected by enterocyte damage due to diarrhoea and CCB competition.Keywords
This publication has 25 references indexed in Scilit:
- Impact of MDR1 and CYP3A5 on the oral clearance of tacrolimus and tacrolimus-related renal dysfunction in adult living-donor liver transplant patientsPharmacogenetics and Genomics, 2008
- Tacrolimus pharmacokinetics and pharmacogenetics: influence of adenosine triphosphate‐binding cassette B1 (ABCB1) and cytochrome (CYP) 3A polymorphismsFundamental & Clinical Pharmacology, 2007
- CYP3A5 and CYP3A4 but not MDR1 Single-nucleotide Polymorphisms Determine Long-term Tacrolimus Disposition and Drug-related Nephrotoxicity in Renal RecipientsClinical Pharmacology & Therapeutics, 2007
- Severe elevations of FK506 blood concentration due to diarrhea in renal transplant recipientsClinical Transplantation, 2004
- Immunosuppressive Interactions among Calcium Channel Antagonists and Selected Corticosteroids and Macrolides Using Human whole Blood LymphocytesDrug Metabolism and Pharmacokinetics, 2004
- C3435T polymorphism in the MDR1 gene affects the enterocyte expression level of CYP3A4 rather than Pgp in recipients of living-donor liver transplantationPharmacogenetics, 2002
- Tacrolimus and diarrhea: Pathogenesis of altered metabolismPediatric Transplantation, 2001
- Diltiazem Increases Tacrolimus ConcentrationsAnnals of Pharmacotherapy, 1999
- SERIOUS INTERACTION BETWEEN MIBEFRADIL AND TACROLIMUS1Transplantation, 1998
- Clinical features of nosocomial rotavirus infection in pediatric liver transplant recipientsClinical Transplantation, 1995